Stage I-IIA Non-Bulky Hodgkin's Lymphoma. Is Further Distinction Based on Prognostic Factors Useful? The Stanford Experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stage I-IIA Non-Bulky Hodgkin's Lymphoma. Is Further Distinction Based on Prognostic Factors Useful? The Stanford Experience

Published:2011-12 Issue:5 Volume:81 Page:1374-1379
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Advani Ranjana H.,Hoppe Richard T.,Maeda Lauren S.,Baer David M.,Mason Joseph,Rosenberg Saul A.,Horning Sandra J.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference18 articles.

1. Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC lymphoma group controlled clinical trials: 1964-1987;Tubiana;Blood,1989

2. Treatment of Hodgkin's disease: Results and current concepts of the German Hodgkin's Lymphoma Study Group;Sieber;Ann Oncol,2000

3. A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease;Hasenclever;N Engl J Med,1998

4. Is the international prognostic score for advanced stage Hodgkin's disease applicable to early stage patients? German Hodgkin Lymphoma Study Group;Franklin;Ann Oncol,2000

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic role of red blood cell distribution width and platelet/lymphocyte ratio in early-stage classical Hodgkin lymphoma;Future Oncology;2022-05

2. Long-term outcomes of patients with unfavorable stage I–II classic Hodgkin lymphoma treated with Stanford V chemotherapy and limited field irradiation;Leukemia & Lymphoma;2020-05-30

3. Effect of Radiation Therapy on Survival in Hodgkin’s Lymphoma: A SEER Data Analysis;Anticancer Research;2017-05-29

4. ACR Appropriateness Criteria® Hodgkin Lymphoma—Unfavorable Clinical Stage I and II;American Journal of Clinical Oncology;2016-08

5. Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial;Journal of Clinical Oncology;2015-06-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3